These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22112605)

  • 1. Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndrome.
    Fitch K; Abbara S; Lee H; Stavrou E; Sacks R; Michel T; Hemphill L; Torriani M; Grinspoon S
    AIDS; 2012 Mar; 26(5):587-97. PubMed ID: 22112605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lifestyle modification and metformin on irisin and FGF21 among HIV-infected subjects with the metabolic syndrome.
    Srinivasa S; Wong K; Fitch KV; Wei J; Petrow E; Cypess AM; Torriani M; Grinspoon SK
    Clin Endocrinol (Oxf); 2015 May; 82(5):678-85. PubMed ID: 25130061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial.
    Hadigan C; Corcoran C; Basgoz N; Davis B; Sax P; Grinspoon S
    JAMA; 2000 Jul; 284(4):472-7. PubMed ID: 10904511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium.
    Goldberg RB; Aroda VR; Bluemke DA; Barrett-Connor E; Budoff M; Crandall JP; Dabelea D; Horton ES; Mather KJ; Orchard TJ; Schade D; Watson K; Temprosa M;
    Circulation; 2017 Jul; 136(1):52-64. PubMed ID: 28476766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of Mediterranean diet and metformin to prevent age-related diseases in people with metabolic syndrome.
    Pasanisi P; Gargano G; Gaetana Di Mauro M; Cortellini M; Casagrande A; Villarini A; Bruno E; Roveda E; Saibene G; Venturelli E; Berrino F
    Tumori; 2018; 104(2):137-142. PubMed ID: 28106245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.
    Orchard TJ; Temprosa M; Goldberg R; Haffner S; Ratner R; Marcovina S; Fowler S;
    Ann Intern Med; 2005 Apr; 142(8):611-9. PubMed ID: 15838067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance.
    Hadigan C; Meigs JB; Rabe J; D'Agostino RB; Wilson PW; Lipinska I; Tofler GH; Grinspoon SS;
    J Clin Endocrinol Metab; 2001 Feb; 86(2):939-43. PubMed ID: 11158071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lifestyle modification and metformin therapy on emerging cardiovascular risk factors in overweight Indian women with polycystic ovary syndrome.
    Rajagopal G; Reddy AP; Venkata Harinarayan C; Suresh V; Bitla A; P V L N Rao S; Sachan A
    Metab Syndr Relat Disord; 2012 Aug; 10(4):273-9. PubMed ID: 22468948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: A systematic review and meta-analysis.
    Kim CH; Chon SJ; Lee SH
    Sci Rep; 2020 May; 10(1):7802. PubMed ID: 32385376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Conjugated Linoleic Acid and Metformin on Insulin Sensitivity in Obese Children: Randomized Clinical Trial.
    Garibay-Nieto N; Queipo-García G; Alvarez F; Bustos M; Villanueva E; Ramírez F; León M; Laresgoiti-Servitje E; Duggirala R; Macías T; Cuevas S; Jalife A; Fonseca-Sánchez M; Serratos F; López-Alvarenga JC
    J Clin Endocrinol Metab; 2017 Jan; 102(1):132-140. PubMed ID: 27778642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study.
    Wiegand S; l'Allemand D; Hübel H; Krude H; Bürmann M; Martus P; Grüters A; Holl RW
    Eur J Endocrinol; 2010 Oct; 163(4):585-92. PubMed ID: 20639355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.
    Lo J; Lu MT; Ihenachor EJ; Wei J; Looby SE; Fitch KV; Oh J; Zimmerman CO; Hwang J; Abbara S; Plutzky J; Robbins G; Tawakol A; Hoffmann U; Grinspoon SK
    Lancet HIV; 2015 Feb; 2(2):e52-63. PubMed ID: 26424461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased coronary artery calcium score and noncalcified plaque among HIV-infected men: relationship to metabolic syndrome and cardiac risk parameters.
    Fitch KV; Lo J; Abbara S; Ghoshhajra B; Shturman L; Soni A; Sacks R; Wei J; Grinspoon S
    J Acquir Immune Defic Syndr; 2010 Dec; 55(4):495-9. PubMed ID: 20720497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy.
    Kohli R; Shevitz A; Gorbach S; Wanke C
    HIV Med; 2007 Oct; 8(7):420-6. PubMed ID: 17760733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acupuncture treatment for insulin sensitivity of women with polycystic ovary syndrome and insulin resistance: a study protocol for a randomized controlled trial.
    Li J; Ng EH; Stener-Victorin E; Hu Z; Shao X; Wang H; Li M; Lai M; Xie C; Su N; Yu C; Liu J; Wu T; Ma H
    Trials; 2017 Mar; 18(1):115. PubMed ID: 28274268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.
    Ratner R; Goldberg R; Haffner S; Marcovina S; Orchard T; Fowler S; Temprosa M;
    Diabetes Care; 2005 Apr; 28(4):888-94. PubMed ID: 15793191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).
    Ramachandran A; Snehalatha C; Mary S; Mukesh B; Bhaskar AD; Vijay V;
    Diabetologia; 2006 Feb; 49(2):289-97. PubMed ID: 16391903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a lifestyle modification program in HIV-infected patients with the metabolic syndrome.
    Fitch KV; Anderson EJ; Hubbard JL; Carpenter SJ; Waddell WR; Caliendo AM; Grinspoon SK
    AIDS; 2006 Sep; 20(14):1843-50. PubMed ID: 16954725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors.
    Martínez E; Domingo P; Ribera E; Milinkovic A; Arroyo JA; Conget I; Pérez-Cuevas JB; Casamitjana R; de Lazzari E; Bianchi L; Montserrat E; Roca M; Burgos R; Arnaiz JA; Gatell JM
    Antivir Ther; 2003 Oct; 8(5):403-10. PubMed ID: 14640387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials.
    Hoeger K; Davidson K; Kochman L; Cherry T; Kopin L; Guzick DS
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4299-306. PubMed ID: 18728175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.